NEW AGE FOR NUCLEAR MEDICINE Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of...
This really important piece of work looks at the the landscape of molecular alterations in pancreatic NETs and NETs of the small intestine. We know that Neuroendocrine Neoplasms are heterogenous and they they display a huge variability and behaviour. Some behave...
We are pleased to announce the 2019 round of the UKINETS and NET Patient Foundation research grant in support of NET research. This is open to basic science, clinical and translational researchers from investigators in the UK and Ireland. Applicants must be UKINETS...
Mylan, the marketing authorisation holder for Creon, has decided to discontinue the manufacture and distribution of Creon 40K from June 2019. It’s important to note that this decision is not associated with any safety or efficacy findings. Why have Mylan...
On the 20th March 2019 the NET Patient Foundation attended the ‘Theranostics is here and now’ meeting, arranged by the Royal Free Hospital and University College London UCL). The meeting was an update by recognised experts highlighting advances in nuclear...
The NET Patient Foundation and the Association for Multiple Endocrine Neoplasia Disorders (AMEND) are developing a joint research strategy to ensure that each charity’s research funds are directed towards the most appropriate areas of research. As a patient, your...
